PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, published by WILEY, serves as a premier platform for the dissemination of cutting-edge research in the field of food science and technology. With an ISSN of 0950-5423 and E-ISSN 1365-2621, this journal has been committed to publishing high-quality research since 1966 and is set to continue its impactful contributions through 2024. Recognized for its excellence, it holds a Q1 ranking in Food Science and a Q2 ranking in Industrial and Manufacturing Engineering as of 2023. The journal ranks #95/384 in Industrial and Manufacturing Engineering and #100/389 in Food Science on Scopus, placing it within the top quartiles of these fields. Although it does not currently offer Open Access, researchers and professionals benefit from access to a wealth of knowledge that advances understanding in both applied and theoretical aspects of food science. This journal is indispensable for anyone in the academic and professional domains who seeks to stay abreast of innovations and trends shaping the food industry.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY is a premier journal published by Taylor & Francis Ltd that focuses on the latest advancements and innovations in the field of pharmaceutical science. Established in 1996, this journal has evolved to encompass a wide array of interdisciplinary studies relevant to drug development, formulation technology, and delivery systems, serving as a platform for researchers and professionals to share groundbreaking findings. With an impressive impact factor and ranked in both Q2 in Pharmaceutical Science and Q3 in Medicine (miscellaneous), it positions itself among the top-tier journals in pharmacology and toxicology. The journal's insights are critical for scholars and practitioners aiming to enhance therapeutic efficacy and safety. Access options for the content remain traditional, thus supporting a comprehensive approach to scientific literature. Throughout its converged years up to 2024, PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY continues to play a vital role in shaping pharmaceutical education and practice.

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, published by MARY ANN LIEBERT, INC, is a distinguished journal dedicated to advancing the field of aerosol medicine and pharmacology. With an ISSN of 1941-2711 and E-ISSN 1941-2703, the journal has established itself as an essential resource for researchers and professionals specializing in pharmaceutical sciences and pulmonary medicine. Ranking in the Q2 category across multiple disciplines, including Pharmaceutical Science and Pulmonary and Respiratory Medicine, it holds notable Scopus rankings, with a percentile of 78th in Pulmonary and Respiratory Medicine. The journal offers open access options, ensuring that cutting-edge research is readily available to a global audience. With converged years from 2008 to 2024, the Journal of Aerosol Medicine and Pulmonary Drug Delivery continues to serve as a vital platform for disseminating innovative research findings, clinical practice insights, and technological advancements in drug delivery systems, thereby significantly impacting therapeutic strategies for respiratory diseases.

SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

Journal of Dermatology & Dermatologic Surgery (JDDS) is a premier open access journal published by Wolters Kluwer Medknow Publications since 2018. This journal serves as a vital platform for the dissemination of cutting-edge research and advancements in the field of dermatology and dermatologic surgery. With its ISSN 2352-2410 and E-ISSN 2352-2429, JDDS strives to present high-quality articles that encompass clinical studies, innovative surgical techniques, and comprehensive reviews, thereby catering to the interests of researchers, medical professionals, and students alike. The journal has gained recognition within the academic community, evidenced by its Scopus ranks, placing it 237th out of 551 in the Medicine - Surgery category and 70th out of 142 in Medicine - Dermatology. The open access model not only enhances visibility but also encourages global collaboration and knowledge sharing in the rapidly evolving field of dermatology. Targeting the needs of diverse audiences, JDDS continues to foster an environment for scholarly communication and contributes significantly to the advancement of dermatologic sciences.

The Journal of Cosmetic and Laser Therapy, published by TAYLOR & FRANCIS INC in the United Kingdom, serves as a vital resource for professionals, researchers, and students in the fields of dermatology, surgery, and cosmetic medicine. Since its inception in 1999, this peer-reviewed journal has sought to advance knowledge and practice in the burgeoning fields of cosmetic and laser treatments, offering a platform for scholarly articles that explore novel techniques, clinical outcomes, and emerging trends. With an impressive categorization in the 2023 Quartiles showcasing its influence—Q3 in Dermatology and Medicine, and Q2 in Surgery—the journal reflects a commendable impact within the community. Although not an Open Access journal, it provides access to essential information and rigorous research that aids in the development and refinement of treatment protocols. The Scopus ranks further emphasize its significance, particularly in Medicine and Surgery, where it holds positions in the 57th and 52nd percentiles respectively—underscoring its commitment to quality and relevance. As the landscape of cosmetic treatments continues to evolve, the Journal of Cosmetic and Laser Therapy remains an indispensable reference for those looking to stay at the forefront of advancements in this dynamic field.

Journal of Chemical Metrology is a vital resource in the evolving fields of Analytical Chemistry, Electrochemistry, Spectroscopy, and Toxicology, published by ACG PUBLICATIONS in Turkey. With a focus on advancing the understanding and application of chemical metrology, this journal aims to bridge gaps in quantitative analysis, offering researchers and professionals a platform to disseminate groundbreaking studies and methodologies. Although it operates under a traditional access model, readers can benefit from its insights as the journal continues to gain recognition with its 2023 rankings placing it in the Q3 and Q4 categories across various scientific disciplines. From its inception in 2019 to its projected convergence in 2024, the journal has been instrumental in fostering collaboration and innovation in chemical sciences, making it an essential tool for students and researchers dedicated to enhancing analytical techniques and ensuring safety through effective toxicological assessments.

JOURNAL OF FOOD SCIENCE, published by Wiley, is a premier journal dedicated to advancing the field of food science, bridging the gap between fundamental research and practical application. With an impressive impact factor reflecting its authoritative status, the journal is ranked in the Q1 quartile for Food Science in 2023 and boasts a Scopus ranking of #71 out of 389, placing it in the 81st percentile within Agricultural and Biological Sciences. First launched in 1936, the journal continues to serve as an essential platform for researchers, professionals, and students to disseminate innovative studies and reviews that address critical issues in food quality, safety, and technology. While not currently offering open access, its rigorous peer-review process ensures the dissemination of high-quality and impactful research. Researchers engaged in the vital disciplines of food science will find this journal indispensable for keeping abreast of cutting-edge developments in the field.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.